I‐Te Lee
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 24
- Diabetes Management and Research 19
- Diabetes Treatment and Management 17
- Nephrology 23
- Chronic Kidney Disease and Diabetes 21
- Co-authors
- Chuen‐Mao Yang (27 shared papers)Wayne Huey‐Herng Sheu (108 shared papers)Wen‐Jane Lee (68 shared papers)Chih‐Chung Lin (15 shared papers)Shih‐Yi Lin (54 shared papers)Yin‐Ching Chan (8 shared papers)Jun‐Sing Wang (45 shared papers)Li‐Der Hsiao (14 shared papers)
- Journals
- Clinica Chimica Acta (12 papers)Medicine (10 papers)PLoS ONE (9 papers)Scientific Reports (8 papers)Diabetology & Metabolic Syndrome (8 papers)
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
I‐Te Lee
225 papers receiving 11.3k citations
I‐Te Lee's Hit Papers
Peers
Comparison fields: 5 of 156
- Endocrinology, Diabetes and Metabolism 3.2k
- Nephrology 821
- Genetics 2k
- Cardiology and Cardiovascular Medicine 1.2k
- Pharmacology 471
Countries citing papers authored by I‐Te Lee
This map shows the geographic impact of I‐Te Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Te Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Te Lee more than expected).
Fields of papers citing papers by I‐Te Lee
This network shows the impact of papers produced by I‐Te Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Te Lee. The network helps show where I‐Te Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Te Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2345 |
| 2 | Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease Hit paper breakdown → | 2017 | 714 |
| 3 | Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Hit paper breakdown → | 2023 | 559 |
| 4 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 498 |
| 5 | Rare and low-frequency coding variants alter human adult height Hit paper breakdown → | 2017 | 483 |
| 6 | 2012 | 374 | |
| 7 | The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals Hit paper breakdown → | 2016 | 335 |
| 8 | 2017 | 252 | |
| 9 | 2016 | 215 | |
| 10 | 2013 | 213 | |
| 11 | 2017 | 209 | |
| 12 | 2014 | 172 | |
| 13 | 2017 | 147 | |
| 14 | 2008 | 132 | |
| 15 | 2017 | 128 | |
| 16 | 2020 | 125 | |
| 17 | 2018 | 116 | |
| 18 | 2009 | 102 | |
| 19 | 2012 | 102 | |
| 20 | 2008 | 100 |
About I‐Te Lee
I‐Te Lee is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Genetics, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 229 papers that have together received 11.7k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (35 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Chronic Kidney Disease and Diabetes (21 papers), Diabetes Management and Research (19 papers), Adipokines, Inflammation, and Metabolic Diseases (17 papers), Diabetes Treatment and Management (17 papers), Lipoproteins and Cardiovascular Health (9 papers) and Peripheral Artery Disease Management (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.2k citations), Nephrology (821 citations), Genetics (2k citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Pharmacology (471 citations). I‐Te Lee has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Chuen‐Mao Yang, Wayne Huey‐Herng Sheu, Wen‐Jane Lee, Chih‐Chung Lin, Shih‐Yi Lin, Yin‐Ching Chan, Jun‐Sing Wang, Li‐Der Hsiao, Chiang‐Wen Lee and Kae‐Woei Liang. Their work appears in journals such as Clinica Chimica Acta, Medicine, PLoS ONE, Scientific Reports and Diabetology & Metabolic Syndrome.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.